Lyell Immunopharma Inc
(LYEL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 123,575 | 98,804 | 120,328 | 105,597 | 100,299 |
| Marketable Securities | 196,049 | 177,986 | 180,849 | 264,930 | 340,248 |
| TOTAL | $328,201 | $282,214 | $309,178 | $379,594 | $450,045 |
| Non-Current Assets | |||||
| PPE Net | 36,722 | 39,115 | 44,195 | 48,200 | 88,047 |
| Investments And Advances | 19,000 | 39,059 | 47,949 | 32,014 | 39,112 |
| Other Non-Current Assets | 24,042 | 25,065 | 28,476 | 31,051 | 42,011 |
| TOTAL | $79,764 | $103,239 | $120,620 | $111,265 | $169,170 |
| Total Assets | $407,965 | $385,453 | $429,798 | $490,859 | $619,215 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,568 | 8,904 | 10,117 | 12,966 | 3,596 |
| Accrued Expenses | 29,310 | 27,999 | 31,168 | 40,822 | 29,009 |
| Other current liabilities | N/A | N/A | N/A | N/A | 907 |
| TOTAL | $31,878 | $36,903 | $41,285 | $53,788 | $33,512 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 46,966 | 49,627 | 51,992 | 54,247 | 55,006 |
| TOTAL | $46,966 | $49,627 | $51,992 | $54,247 | $55,006 |
| Total Liabilities | $78,844 | $86,530 | $93,277 | $108,035 | $88,518 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,218 | 19,211 | 14,767 | 14,761 | 13,961 |
| Common Shares | 2 | 1 | 30 | 1 | 26 |
| Retained earnings | -1,478,831 | -1,439,985 | -1,397,301 | -1,345,106 | -1,153,171 |
| Other shareholders' equity | 201 | 57 | 158 | 291 | 760 |
| TOTAL | $329,121 | $298,923 | $336,521 | $382,824 | $530,697 |
| Total Liabilities And Equity | $407,965 | $385,453 | $429,798 | $490,859 | $619,215 |